( May 13, 2025, 2:01 PM EDT) -- NEW YORK — CVS Health Corp. faced the same trends in the wake of the COVID-19 pandemic as other insurers, and it was those difficulties that impacted post-acute care prior authorization denials and the company’s economic performance, not an attempt to divest itself of an illicit artificial intelligence scheme in response to changes in the Medicare program, an insurer tells a federal judge in New York in seeking dismissal of a securities action....